By Declining a Heart Transplant, She Gives Her Daughter a New Lease on Life

A mother’s decision to decline a heart transplant has created an extraordinary opportunity for her daughter, highlighting the profound choices families face when confronting life-threatening illness and the complexities of organ donation within families.

An Unlikely Recovery Defies Medical Expectations

Against all odds, a 12-year-old girl from Thane has become a symbol of hope in the world of severe pediatric cardiomyopathy. Supervised by Dr. Tanuja Karande, her case stands apart: her heart function had plummeted to a perilous 5 percent—alarmingly lower than the healthy average of around 60 percent for children. The child’s condition rapidly deteriorated, with breathlessness, appetite loss, and an inability to walk; by all accounts, doctors were preparing for the only remaining option: a heart transplant.

A Mother’s Intuition Reshapes Medical Decisions

Yet, just as the opportunity for a transplant presented itself, an unexpected twist arose. The girl’s mother refused consent for the life-saving procedure. Driven by conviction more than medical rationale, she insisted: “I know my daughter will recover with medication. Please treat her—I don’t want this surgery.” Her stance left both her husband wavering and the medical team facing a dilemma few would envy. As Dr. Karande admits, refusing a transplant at this stage verges on declining a chance at survival. Still, after careful discussion, a compromise emerged: they would proceed with intensive pharmacological treatment while keeping transplantation as a fallback should her condition worsen.

Pioneering Treatment Spurs Remarkable Progress

The therapeutic approach that followed was anything but standard. The care team introduced new generations of heart failure drugs—typically reserved for adults in India—into the child’s regimen. Caution was paramount; used incorrectly, these medications can hasten decline. In this instance, however, they were well-tolerated and augmented by two additional advanced compounds. With weekly consultations and unwavering parental involvement, improvements quickly became evident:

After two decades practicing medicine, Dr. Karande recalls witnessing only a handful of such recoveries among children afflicted by genetic forms of this disease.

The Urgent Need for Systemic Change

Yet amid celebration lies cause for concern. This extraordinary turnaround spotlights significant shortcomings: limited early detection efforts, poor awareness among healthcare professionals and families alike, and shockingly low rates of pediatric organ donation—fewer than 0.9 donors per million residents in India. And with nearly one-third of children suffering from heart failure likely to require a transplant someday, such gaps cannot be ignored.

Cases like this remind the medical community—and families—that sometimes hope prevails where data and guidelines fall short.